ToothWave Calculus Reduction and Accumulation Prevention Study
Safety and Efficacy of the ToothWave™ (Model H7001) Home Use Device for Calculus Reduction and Prevention of Calculus Accumulation
1 other identifier
interventional
90
1 country
1
Brief Summary
The objective of the study is to evaluate the safety and efficacy of the home-use device ToothWave (Model H7001) for calculus reduction and the prevention of calculus accumulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2020
CompletedFirst Submitted
Initial submission to the registry
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2020
CompletedApril 23, 2021
March 1, 2020
5 months
October 15, 2020
April 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Calculus
A significant calculus reduction in the treatment group as compared to the control group following 6 or 12 weeks of treatment.
6-12 weeks
Secondary Outcomes (3)
reduction of calculus compared to baseline
6-12 weeks
Oral health
12 weeks
prevention of calculus accumulation
6-12 weeks
Study Arms (2)
Treatment group
EXPERIMENTALThe treatment is conducted with the ToothWave toothbrush Intervention: brushing with Radio frequency (RF)-utilizing powered toothbrush
Control group
EXPERIMENTALRegular powered toothbrush Intervention: brushing with a regular powered toothbrush with no RF
Interventions
RF-utilizing Powered toothbrush
Eligibility Criteria
You may qualify if:
- Adult subjects aged 18 years and older, that are in good health.
- Subject must have a minimum of 16 natural teeth, including six mandibular anterior teeth with no crowns or veneers.
- The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
- The subjects should be willing to comply with the study procedures and schedule, including the follow up visits.
- Subjects must demonstrate a propensity for calculus formation as evidenced by at least 9 mm of calculus on the lingual surfaces of the six mandibular teeth, following the 2-month run-in phase.
You may not qualify if:
- Subjects who had a medical condition requiring antibiotic premedication prior to dental procedures.
- Regular users of a chlorhexidine mouthrinse.
- Any oral condition or pathosis that could interfere with study compliance and/or examination procedures (e.g., widespread caries, chronic neglect, advanced periodontal dis-ease).
- Current or history of oral cavity cancer or oropharyngeal cancer.
- Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
- Pregnant or nursing by subject report.
- Subjects that do not brush regularly.
- Any condition that might make it unsafe for the subject to participate in this study, at the discretion of the investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Salus Research
Fort Wayne, Indiana, 46825, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffery L Milleman, DDS, MPA
Salus Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The Outcomes Assessors will not be exposed to the type of brush the subject is using or to the group they are assigned to (treatment or control).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2020
First Posted
October 22, 2020
Study Start
July 15, 2020
Primary Completion
December 10, 2020
Study Completion
December 10, 2020
Last Updated
April 23, 2021
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share